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Abstract
HIV-1 infection increases the risk and severity of malaria by poorly defined mechanisms. We investigated the effect of HIV-
1Ba-L infection of monocyte-derived macrophages (MDM) on phagocytosis of opsonised P. falciparum infected erythrocytes
(IE) and subsequent proinflammatory cytokine secretion. Compared to mock-infected MDM, HIV-1 infection significantly
inhibited phagocytosis of IE (median (IQR) (10 (0–28) versus (34 (27–108); IE internalised/100 MDM; p=0.001) and decreased
secretion of IL-6 (1,116 (352–3,387) versus 1,552 (889–6,331); pg/mL; p=0.0078) and IL-1b (16 (7–21) versus 33 (27–65); pg/
mL; p=0.0078). Thus inadequate phagocytosis and cytokine production may contribute to impaired control of malaria in
HIV-1 infected individuals.
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Introduction
Due to the high prevalence of HIV-1 in Plasmodium falciparum
endemic regions such as sub-Saharan Africa, co-infections are
common in pregnant women, affecting approximately 1 million
pregnancies each year [1]. HIV-1 co-infection is associated with
impaired control of malaria resulting in more frequent and higher
peripheral and placental parasite densities [2]. HIV-1 infection
increases the risk and severity of pregnancy-associated malaria by
poorly defined mechanisms.
Primigravid women are at increased risk of placental malaria
characterised by the accumulation of P. falciparum infected
erythrocytes (IE) in the intervillous spaces of the placenta.
Complications of malaria in pregnancy include severe anaemia
and low infant birth weight. These complications are associated
with monocyte accumulation in the maternal intervillous circula-
tion of the placenta, termed intervillositis [3], and with increased
placental blood TNF concentrations [4]. Monocytes and macro-
phages in the intervillous space frequently contain the malaria
pigment haemozoin, and intact IE are also seen within these cells.
This phagocytosis represents an important mechanism of control-
ling blood trophozoite-stage parasites and is enhanced by antibody
opsonisation [5].
In the placenta, the principal target for opsonising antibody on
the IE surface appears to be the variant surface antigen
VAR2CSA, which mediates binding to chondroitin sulphate A
(CSA) present on the placental syncytiotrophoblast [6]. Antibodies
against VAR2CSA block placental sequestration and opsonise IE
for phagocytic uptake. Antibodies to VAR2CSA develop with
exposure during successive gravidities, and are associated with
decreased prevalence and intensity of infection and with
protection against low birth weight and severe maternal anaemia
[7,8,9]. We have demonstrated that IgG opsonic activity in serum
is associated with protection from treatment failure [10] and is
gravidity dependent [11] in pregnant women in Malawi. The
relative risk of malaria associated with HIV-1 infection is greatest
in multigravidae [12], consistent with an effect on acquired
antibody-dependent immunity. HIV-1 infection impairs develop-
ment of opsonising antibodies to pregnancy-associated variant
surface antigens including VAR2CSA [13] and we have
demonstrated lower serum opsonic activity in multigravid women
with malaria and HIV-1 co-infection [14]. Opsonising antibodies
engage Fcc receptors which promote phagocytic ingestion and
induce kinase and transcription factor activation which orches-
trates proinflammatory cytokine secretion [15,16,17]. Signalling
mechanisms that result in this cytokine profile in response to intact
IE are presently unknown, but clinical observations confirm that
proinflammatory cytokines and b chemokines are secreted by
intervillous macrophages and monocytes in response to IE [18].
This alteration in cytokine balance is important for clearance of IE
from the placenta, but it is also associated with maternal anaemia
and premature delivery [4,19,20,21,22].
We hypothesised that HIV-1 may inhibit opsonic phagocytosis
thereby impairing IE clearance resulting in increased susceptibility
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our understanding of the mechanisms by which HIV-1 co-
infection impairs immunity to malaria in pregnancy, we
investigated the effects of in vitro HIV-1 infection on phagocytic
uptake and cytokine secretion by monocyte-derived macrophage
(MDM) in response to opsonised CS2-IE (an established model for
CSA binding placental strains of P. falciparum). Compared to mock-
infected MDM, HIV-1 infection significantly inhibited phagocy-
tosis of opsonised IE without altering MDM viability, and
decreased secretion of IL-6 and IL-1b. These results may explain
the increased risk and severity of maternal malaria in the setting of
HIV-1 infection.
Materials and Methods
Isolation of monocytes and culture of MDM
Human PBMC were obtained from Buffy Coats separated from
volunteer blood donations (Australian Red Cross Blood Service,
Southbank, Victoria, Australia) using Ficoll-Paque
TM density
gradient centrifugation. Monocytes were isolated from this cell
fraction by counter-current elutriation using a Beckman J-6M/E
centrifuge equipped with a JE 5.0 rotor. Preparations yielded 50–
100610
6 monocytes and were 90–92% pure with a viability of
.98% determined by flow cytometry and trypan blue exclusion
techniques respectively (data not shown). Monocyte-derived
macrophages (MDM) were prepared by culturing freshly isolated
monocytes adhered to plastic in Iscove’s modified Dulbecco’s
medium (Invitrogen) containing 10% non-malaria immune heat-
inactivated human serum obtained from the Red Cross Blood
Service, Sydney, Australia supplemented with 2 mM glutamine,
100 U/mL penicillin G and 100 mg/ml streptomycin sulphate
(IH10 medium). MDM were cultured for 14 days at a cell density
of 50,000 per well in 96-well plates and 2.5610
5 per well in 24-
well plates.
Infection of MDM with HIV-1Ba-L
HIV-1Ba-L was routinely passaged in human MDM and purified
from culture media by centrifugation (60 min, 4uC, 150,0006g)
through a 20% sucrose cushion in Ca
2+/Mg
2+ PBS. Viral stocks
were analysed by micro reverse transcriptase (RT) assay which
quantifies the enzymatic activity of HIV-1 RT by measuring the
incorporation of [
33P]-labelled dTTP into DNA from a synthetic
RNA primer/template, and is expressed as counts per minute of
radioactivity incorporated into DNA per hour per microlitre of
culture medium [23]. Laboratory stocks of HIV-1Ba-L were
verified by comparing the sequence of the hypervariable V3 loop
of the Env gene to that of the reference HXB2 strain, amplified
using the following primers: Forward: 59- ACAATGYACA-
CATGGAATTARGCCA-39, Reverse: 59-AGAAAAATT-
CYCCTCYACAATTAAA-39. MDM were infected with HIV-
1Ba-L at a multiplicity of infection (MOI) of between 0.1 and
1.0 and cultured for a further 7 days before use in phagocytosis
or cytokine assays. Where indicated, MDM were primed with
IFNc (100 ng/mL, R&D Systems) 5 days after HIV-1Ba-L
infection to allow 48 hr priming of macrophages before exposure
to phagocytic targets. Culture medium was changed every 3–4
days and infection was monitored by measuring RT activity in
culture medium 7 days post HIV-1Ba-L infection; using this
protocol, the percentage of MDM productively infected with HIV-
1Ba-L was 30–70% [24,25]. MDM viability was measured using
reduction of sodium 39-[1-(phenylaminocarbonyl)-3,4-tetrazoli-
um]-bis(4-methoxy-6-nitro) benzene sulphonic acid (XTT) as an
indicator according to the manufacturer (Roche, Cell Proliferation
Kit II).
Culture and purification of parasitised erythrocytes
The laboratory-adapted P. falciparum line CS2 resembles
placental-type isolates based upon VAR2CSA expression, binding
to CSA and recognition by serum in a pregnancy and gravidity-
specific manner. CS2 was cultured in unexpired human group O
+
erythrocytes (Australian Red Cross Blood Service). Cells were
maintained at 5–12% parasitemia in RPMI 1640-HEPES medium
supplemented with 0.25% AlbumaxII (Gibco) and 0.2% w/vol
NaHCO3. Cultures were synchronized by gelatine flotation every
1 to 2 weeks and adhesion to CSA was regularly checked to ensure
high level binding. Cultures were tested regularly to exclude
Mycoplasma contamination. Trophozoite-stage parasites were
purified by density gradient centrifugation using layers of 80%,
60% and 40% Percoll in supplemented RPMI 1640-HEPES.
Purified IE collected from the 60% layer were washed three times
and resuspended in supplemented RPMI. Preparations were
analysed microscopically for stage and contamination by unin-
fected erythrocytes, and a purity between 92–95% was routinely
obtained.
Opsonisation of CS2 Trophozoites
IE were left unopsonised or opsonised with 9% heat-inactivated
pooled patient serum (PPS) from Malawian HIV-uninfected
pregnant women with malaria, for 30 min at room temperature
as described [14]. IE were examined microscopically to verify that
opsonisation at these concentrations did not induce agglutination.
Opsonised IE were washed and resuspended in PBS at 1610
8 per
mL and used immediately.
Measurement of phagocytosis and cytokine secretion
IE were added at 1610
6 per well to MDM cultured in 96-well
plates (a target to cell ratio of 20:1) and incubated for 1 hr.
Phagocytosis was determined by measuring internalised haemo-
globin using a colourimetric assay as described [14]. The
haemoglobin content was converted to equivalents of IE ingested
by reference to a standard curve of known amounts of IE from the
same preparation, and phagocytosis was expressed as a phagocytic
index representing IE ingested per 100 MDM. At the indicated
time point, media from triplicate wells was collected and pooled,
then analysed for cytokine secretion using cytokine bead array (BD
Biosciences, Human Inflammatory Cytokine Kit).
Measurement of cytokine gene expression by
quantitative real time PCR
MDM were cultured in 24-well plates and exposed to IE for
various times then lysed in lysis buffer A (0.1 M Tris HCl, pH 7.5
containing 1% lithium dodecyl sulphate, 0.5 M LiCl, 10 mM
EDTA, 5 mM DTT) to extract total cellular RNA. Cellular
mRNA was isolated from extracts using oligo(dT) magnetic beads
(GenoPrep
TM, GenoVision), then cDNA was prepared using a
Transcriptor First Strand cDNA Synthesis Kit (Roche) followed by
amplification of cytokine cDNAs by quantitative real time PCR in
BrilliantH SYBRH Green qPCR Master Mix (Stratagene) using the
following primer sets [26]: TNF: Forward: 59 CCCCAGG-
GACCTCTCTCTAATC 39, Reverse: 59 GGTTTGCTACAA-
CATGGGCTACA 39, NM_000594; IL-1b: Forward: 59
CCTGTCCTGCGTGTTGAAAGA 39, Reverse: 59
GGGAACTGGGCAGACTCAAA 39, NM_000576; IL-6: For-
ward: 59 CAATCTGGATTCAATGAGGAGAC 39, Reverse: 59
CTCTGGCTTGTTCCTCACTACTC 39, NM_000600.
Messenger RNA levels were determined by quantitative real
time PCR (Stratagene MX-3000) using the comparative threshold
method with GAPDH as a reference gene. PCR conditions were
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and 72uC for 30 sec. In all cases, amplification products from the
last cycle were resolved by 1% agarose gel electrophoresis
containing 16 SYBR SafeH DNA gel stain (Invitrogen) and
visualised using a Gel Doc XR Molecular Imager (Bio-Rad) to
verify single amplification products.
Statistical Analysis
Statistical comparisons between groups were performed using
Mann-Whitney non-parametric U test or for paired comparisons a
Wilcoxon signed rank test. All statistical analysis was carried out
using Prism 5.0 software (GraphPad Software). Significance was
defined as a probability value below 0.05
Ethics
Sera used to produce the positive pool were collected as part of
studies approved by the College of Medicine Research Ethics
Committee, Blantyre, Malawi and the Melbourne Health Human
Research Ethics Committee, Melbourne. Informed written
consent was obtained from all participants involved in this study.
Results
HIV-1 inhibits antibody dependent uptake of CS2
infected erythrocytes
The effect of HIV-1 infection on macrophage ingestion of
opsonised IE was investigated. Phagocytosis assays were performed
using CS2-IE opsonised with PPS as targets. MDM generated
from eleven different donor monocyte preparations were infected
or mock-infected with the laboratory-adapted macrophage-tropic
strain HIV-1Bal-L. HIV-1 infection significantly inhibited
(p=0.001) ingestion of opsonised IE (9.6 IE internalised per 100
HIV-1Ba-L-infected MDM (IQR: 0–28) compared to 34 IE
internalised per 100 mock-infected MDM (IQR: 27–108);
Figure 1A). HIV-1Ba-L infected or mock-infected MDM did not
phagocytose uninfected erythrocytes or unopsonised IE (data not
shown) and similar results were obtained using IFNc primed
MDM (data not shown). In selected experiments, MDM viability
was assessed to verify that inhibition of phagocytosis was not due
to effects of HIV-1Bal-L infection on cell viability. In six
independent experiments using MDM prepared from different
donor monocytes, no significant difference (p=0.56) in cell
viability was observed between mock-infected and HIV-1Bal-L
infected MDM (Figure 1B). As expected, due to its antiviral effects,
IFNc treatment reduced HIV-1Bal-L production measured at day
seven post-infection from a median of 1040 cpm in the absence of
priming to 599 cpm with priming (p=0.004; Figure 1C).
HIV-1 alters proinflammatory cytokine secretion by MDM
in response to opsonised IE
The effect of HIV-1 infection on cytokine secretion following
opsonised CS2-IE ingestion by MDM was then assessed. Uptake
of opsonised IE significantly increased secretion of TNF, IL-6, IL-
1b and IL-8 in both HIV-1Ba-L infected and mock-infected MDM
primed with IFNc (Figure 2) or unprimed (data not shown). In
response to opsonised IE, HIV-1 infection significantly reduced
IL-6 release (1,116 pg/mL (IQR: 352–3,387) compared to
Figure 1. HIV-1 infection of MDM inhibits phagocytosis of
antibody opsonised CS2 infected erythrocytes. (A). MDM from 11
donors were cultured for 5 days and infected with HIV-1Ba-L (N) at a MOI
of between 0.1 and 1.0 or mock-infected (#) then cultured for an
additional 7 days. IE opsonised with 9% PPS were added at a 20:1 ratio
and phagocytosis was measured at 1 hour. Phagocytic index represents
the number of ingested IE per 100 MDM. Statistical comparisons were
performed in a pair wise manner using the Wilcoxon matched pairs test.
(B). In 6 selected cultures analysed for phagocytosis, XTT assay was
used to measure viability of MDM infected with HIV-1Ba-L (N) or mock-
infected (#) MDM (3 mg/mL XTT, 4 hr, absorbance was read at 450 nm
using a reference wavelength of 650 nm). (C). Effect of IFNc on HIV-1Ba-L
production by MDM. MDM were cultured in triplicate in 96-well plates
for 5 days, infected with HIV-1Ba-L for a further 5 days then primed with
100 ng/mL IFNc where indicated. After 72 hrs media from triplicate
wells was collected and analysed by micro RT assay. Comparisons
between unprimed and primed MDM were made using the Wilcoxon
matched pairs test and a significant difference (p,.05) is indicated.
doi:10.1371/journal.pone.0032102.g001
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(16 pg/mL (IQR: 7–21) compared to 33 pg/mL (IQR: 27–65);
p=0.0078) from mock-infected IFNc primed MDM (Figure 2A
and 2C). Similar results were observed using unprimed MDM
where in response to opsonised IE, HIV-1 infection significantly
reduced IL-6 release (410 pg/mL (IQR: 40–1985) pg/mL
compared to 798 pg/mL (IQR: 276–2671); p=0.015) and IL-1b
release (14 pg/mL (IQR: 5–24) compared to 31 pg/mL (IQR: 8–
73); p=0.039) from mock-infected unprimed MDM (data no
shown).
HIV-1 infection had variable effects on TNF secretion in
response to IE-PPS phagocytic targets (112 pg/mL (IQR: 16–745)
compared to 71 pg/mL (IQR: 7–388); p=0.055) using IFNc
primed MDM and (8 pg/mL (IQR: 3–42) compared to 5 pg/mL
(IQR: 3–9); p=0.078) in unprimed MDM (Figure 2B and data not
shown). No significant decrease in IL-8 secretion was observed in
both primed (p=0.19) and unprimed MDM (p=0.46; Figure 2D
and data not shown). Secretion of IL-12p70 or IL-10 was not
detected in response to IE-PPS (data not shown).
The effect of HIV-1 infection on the kinetics of cytokine
secretion following opsonised CS2-IE ingestion by MDM
prepared from 3 independent donors was assessed (Figure 3). No
difference in IL-1b, TNF and IL-6 secretion was observed in
response to IE-PPS phagocytic targets at 2 hours and 4 hours in
HIV-1 infected MDM compared to mock-infected MDM. From
8 hours onwards a time-dependent decrease in IL-1b, TNF and
IL-6 accumulation in culture medium was detected in HIV-1
infected MDM exposed to IE-PPS (Figure 3).
HIV-1 alters proinflammatory cytokine mRNA production
To determine whether reduced cytokine secretion was due to
HIV-1 mediated decrease of mRNA expression, HIV-1 infected
and uninfected MDM from six additional donors were exposed to
IE-PPS for 1 hour, 2 hours or 4 hours and the levels of IL-1b,
TNF and IL-6 transcripts were measured by qPCR. No significant
decrease in IL-1b mRNA was observed at 2 hours (p=0.17;
Figure 4A), 1 hour (p=0.31; data not shown) or 4 hours (p=0.48;
data not shown) in HIV-1Ba-L infected MDM compared to mock-
infected MDM exposed to IE-PPS. HIV-1 infection had variable
effects on TNF mRNA levels in response to IE-PPS phagocytic
targets. A significant decrease in TNF mRNA was observed at
2 hours (p=0.0087; Figure 4B) but not at 1 hour (p=0.13; data
not shown) or 4 hours (p=0.39; data not shown). In response to
opsonised IE, HIV-1 infection significantly reduced IL-6 mRNA
at 2 hours (p=0.002; Figure 4C), 1 hour (p=0.026; data not
shown) and 4 hours (p=0.04; data not shown).
Discussion
In this study we reveal that HIV-1 infection of MDM inhibits
phagocytosis and decreases proinflammatory cytokine secretion in
response to IE. Insufficient phagocytosis and consequent cytokine
Figure 2. The effect of HIV-1 on cytokine secretion of MDM
exposed to antibody opsonised IE. MDM from 8 donors cultured as
described in Figure 1 were infected with HIV-1Ba-L (N) or mock-infected
(#) and primed for 48 hrs with IFNc then exposed to unopsonised (IE)
or IE opsonised with 9% pooled immune serum (IE-PPS) at a target to
cell ratio of 20:1 for 24 hrs followed by collection of culture medium for
(A) IL-1b,( B) TNF, (C) IL-6 and (D) IL-8 cytokine secretion analysis.
Comparisons of cytokine secretion between cultures infected with HIV-
1Ba-L exposed to IE or IE-PPS, and between HIV-1Ba-L infected and
uninfected cultures exposed to IE-PPS were made using the Wilcoxon
matched pairs test.
doi:10.1371/journal.pone.0032102.g002
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secretion of MDM exposed to antibody opsonised IE. MDM from
3 donors cultured as described in Figure 1 were infected with HIV-1Ba-L
(N) or mock-infected (#) and primed for 48 hrs with IFNc then exposed
to IE opsonised with 9% pooled immune serum (IE-PPS) at a target to
cell ratio of 20:1. At the indicated time points culture supernatants were
collected for (A) IL-1b,( B) TNF and (C) IL-6 cytokine measurement. Data
are means of MDM derived from 3 donors plus-minus SEM. Statistical
analysis was carried out using the generalised estimating equations
method which indicated that mock-infected MDM secreted significantly
higher levels of cytokines compared to HIV-1 infected MDM (p=0.026,
IL-1b; p=0.047, TNF; p=0.019, IL-6).
doi:10.1371/journal.pone.0032102.g003
Figure 4. The effect of HIV-1 on cytokine mRNA levels of MDM
exposed to antibody opsonised IE. MDM from 6 donors cultured in
24-well plates were infected with HIV-1Ba-L (N) or mock-infected (#) and
primed for 48 hrs with IFNc then exposed to IE opsonised with 9%
pooled immune serum (IE-PPS) at a target to cell ratio of 20:1 for 2 hrs
followed by preparation of RNA and cDNA for analysis of (A) IL-1b,( B)
TNF and (C) IL-6 cytokine mRNA levels by qPCR. Comparisons of mRNA
levelsbetweencultures infected with HIV-1Ba-Lor mock-infectedexposed
to IE-PPS were made using the Mann-Whitney non-parametric U test.
doi:10.1371/journal.pone.0032102.g004
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increased risk and severity of pregnancy-associated malaria.
This study demonstrates that HIV-1 infection in vitro signifi-
cantly impairs ingestion of antibody opsonised IE. In agreement,
previous research has reported reduced FccR-dependent phago-
cytosis of IgG-coated erythrocytes by HIV-infected MDM [23,27].
We have previously demonstrated a potential mechanism for
defective FccR-dependent phagocytosis. The macrophage Fcc
receptor family (FccRI, FccRII and FccRIIIa) are responsible for
recognition of IgG-opsonised targets, activating signal transduc-
tion pathways via tyrosine kinases of the Syk/ZAP70 family
leading to target ingestion and cytokine secretion. HIV-1 infection
results in reduced intracellular protein levels of FcRc, the
signalling adaptor protein and chaperone required for FccRI
and III expression and function [23]. Inhibition of subsequent
downstream phosphorylation of Hck and Syk tyrosine kinases is
evident in HIV-infected MDM undergoing Fcc receptor-mediated
phagocytosis. Thus impaired FccR-mediated signalling in HIV-1
infected MDM may explain the decreased phagocytosis of
opsonised IE observed in our analysis. However, decreased IL-6
secretion was also observed in response to unopsonised IE which
are not ingested by MDM. This suggests that HIV impairs other
pathways required for proinflammatory cytokine secretion in
addition to those activated by Fcc receptors.
Inappropriate regulation of inflammatory cytokines by HIV-1
infected macrophages in the context of high IFNc concentrations
may prevent an adequate immune response to parasitemia.
Studies examining cytokine levels in a cohort of HIV-1 infected
women with placental malaria are justified. In partial agreement
with our observations, IFNc, IL-4 and IL-10 production by
intervillous blood mononuclear cells was impaired in HIV infected
women with placental malaria [28]. Our laboratory has identified
a mechanism that may explain these ex vivo observations. HIV-1
infection impairs development of opsonising antibodies to
pregnancy-associated variant surface antigens including
VAR2CSA [11] and lowers the capacity of multigravid pregnant
women to opsonise IE [7,12]. This is expected to decrease
phagocytic parasite clearance in these women. The present study
shows that HIV potentially affects the ability of the phagocytes to
ingest opsonised IE, which would be expected to act in synergy
with decreased plasma opsonic activity to impair clearance of
blood stage parasites.
The reduction in IL-6 cytokine production derived from HIV-1
infected MDM exposed to IE-PPS appears to be at the level of
mRNA expression. We investigated activation of NF-kB signalling
in HIV-1 infected MDM stimulated with opsonised IE but did not
observe any change in this pathway compared to mock-infected
MDM (LEL and JZ, data not shown). The question remains as to
why cytokine mRNA expression is decreased by HIV-1 infection.
Study of the signalling mechanism responsible for the observed
decrease in cytokine secretion is warranted.
We have demonstrated that HIV-1 inhibits ingestion of IE and
subsequent proinflammatory cytokine production by macrophages
which may explain the increased risk and severity of maternal
malaria in the setting of HIV-1 infection. HIV infection therefore
impairs immunity to placental malaria at multiple levels. Given
that HIV co-infection is a major determinant of susceptibility to
maternal malaria, control of HIV with antiretroviral drugs is
critical to minimising the burden of maternal malaria. Whether
effective control of HIV viremia by antiretroviral therapy restores
immunity to maternal malaria is presently unknown.
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